118
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Patient Adherence to Immunosuppressive Therapy in Treatment of Chronic Inflammatory Eye Disease

, BS, , MS, , PhD, , MD & , MD, MS
Pages 5-10 | Received 10 Sep 2022, Accepted 03 Nov 2022, Published online: 28 Nov 2022

References

  • Javidi H, Poonit N, Patel RP, Barry RJ, Rauz S, Murray PI. Adherence to topical medication in patients with inflammatory eye disease. Ocul Immunol Inflamm. 2020 Jan;16:1–6. doi:10.1080/09273948.2019.1699122. Epub ahead of print. PMID: 31944132.
  • Lagina A, Scleritis RK. [Updated 2020 Jun 27]. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499944/
  • Tsirouki T, Dastiridou A, Symeonidis C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26(1):2–16. doi:10.1080/09273948.2016.1196713. Epub 2016 Jul 28. PMID: 27467180.
  • Hornbeak DM, Thorne JE. Immunosuppressive therapy for eye diseases: effectiveness, safety, side effects and their prevention. Taiwan J Ophthalmol. 2015;5(4):156–163. doi:10.1016/j.tjo.2015.03.004.
  • Miraldi Utz V, Bulas S, Lopper S, et al. Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis. Pediatr Rheumatol Online J. 2019 Nov 29;17(1);79. PMID: 31783768; PMCID: PMC6884783. doi:10.1186/s12969-019-0383-9.
  • Ashkenazy N, Saboo US, Robertson ZM, Cao J. The effect of patient compliance on remission rates in pediatric noninfectious uveitis. J AAPOS. 2019 Dec;23(6):334.e1–334.e6. doi:10.1016/j.jaapos.2019.08.280. Epub 2019 Oct 31. PMID: 31678259.
  • Mohanty G, Dash S. Adherence to treatment regimen in uveitis patients in a tertiary hospital in Orissa. Sch J App Med Sci. 2017;7:2710–2715. Tse AP, Shah M, Jamal N, Shaikh A. Glaucoma treatment adherence at a United Kingdom general practice. Eye (Lond). 2016 Aug;30(8):1118-22. doi:10.1038/eye.2016.103. Epub 2016 Jun 3. PMID: 27256302; PMCID: PMC4985664.
  • Morse AR, Seiple WH. Decreasing avoidable vision loss: identifying antecedents of adherence. Clin Ophthalmol. 2020;14:3735–3739. doi:10.2147/OPTH.S278627.
  • Morse AR. Improving medication adherence to reduce vision loss in patients with glaucoma: low hanging fruit? Ophthalmology. 2015 Jul;122(7):1280–1282. doi:10.1016/j.ophtha.2015.04.019. PMID: 26111779.
  • Curtis JR, Bykerk VP, Aassi M, Schiff M. Adherence and persistence with methotrexate in rheumatoid arthritis: a systematic review. J Rheumatol. 2016 Nov;43(11):1997–2009. doi:10.3899/jrheum.151212. Epub 2016 Oct 1. PMID: 27803341.
  • Tse AP, Shah M, Jamal N, Shaikh A. Glaucoma treatment adherence at a United Kingdom general practice. Eye (Lond). 2016 Aug;30(8):1118–1122. doi:10.1038/eye.2016.103. Epub 2016 Jun 3. PMID: 27256302; PMCID: PMC4985664.
  • Wolfram C, Stahlberg E, Pfeiffer N. Patient-reported nonadherence with glaucoma therapy. J Ocul Pharmacol Ther. 2019;35(4):223–228. doi:10.1089/jop.2018.0134.
  • Grossberg R, Gross R. Use of pharmacy refill data as a measure of antiretroviral adherence. Curr HIV/AIDS Rep. 2007 Dec;4(4):187–191. doi:10.1007/s11904-007-0027-4. PMID: 18366950.
  • Vu AF, Kodati S, Lin P, Bodaghi B, Emami-Naeini P; COVID-19 Practice Patterns Study Group. Impact of the COVID-19 pandemic on uveitis patient care. Br J Ophthalmol. 2022 Jan;24: bjophthalmol-2021-320368. doi:10.1136/bjophthalmol-2021-320368. Epub ahead of print. PMID: 35074784; PMCID: PMC8804303.
  • Racette L, Abu SL, Poleon S, Thomas T, Sabbagh N, Girkin CA. The impact of the Coronavirus disease 2019 pandemic on adherence to ocular hypotensive medication in patients with primary open-angle glaucoma. Ophthalmology. 2022 Mar;129(3):258–266. doi:10.1016/j.ophtha.2021.10.009. Epub 2021 Oct 19. PMID: 34673098; PMCID: PMC8523310.
  • Agarwal AK, Sudharshan S, Mahendradas P, et al. Impact of COVID-19 pandemic on uveitis patients receiving immunomodulatory and biological therapies (COPE STUDY). Br J Ophthalmol. 2022 Jan;106(1):97–101. doi:10.1136/bjophthalmol-2020-317417. Epub 2020 Oct 3. PMID: 33011688.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.